We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$124B
AUM Growth
+$12.6B
Cap. Flow
+$4.01B
Cap. Flow %
3.23%
Top 10 Hldgs %
24.28%
Holding
4,396
New
293
Increased
2,114
Reduced
1,559
Closed
268

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$212M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$147M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$119M
4
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$98.2M
5
AMZN icon
Amazon
AMZN
+$68.5M

Top Sells

Rank Stock Value
1
KSU
Kansas City Southern
KSU
+$80.8M
2
AAXJ icon
iShares MSCI All Country Asia ex Japan ETF
AAXJ
+$80M
3
NVDA icon
NVIDIA
NVDA
+$51.5M
4
BABA icon
Alibaba
BABA
+$43.1M
5
VZ icon
Verizon
VZ
+$41.6M

Sector Composition

Rank Sector Weight
1 Technology 15.45%
2 Financials 8.54%
3 Healthcare 8.18%
4 Consumer Discretionary 6.58%
5 Industrials 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHAS
3951
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$40K ﹤0.01%
+15,500
New +$46.8K
HBI
3952
CALL
DELISTED
Hanesbrands
HBI
$39K ﹤0.01%
256,500
-30,100
-11% -$512K
AMRS
3953
CALL
DELISTED
Amyris Inc.
AMRS
$39K ﹤0.01%
17,600
-30,400
-63% -$284K
FCX icon
3954
CALL
Freeport-McMoran
FCX
$96.3B
$38K ﹤0.01%
36,300
-50,900
-58% -$1.93M
AMPE
3955
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$38K ﹤0.01%
224
-492
-69% -$183K
UGP icon
3956
Ultrapar
UGP
$6.39B
$37K ﹤0.01%
13,968
– –
ACER
3957
DELISTED
Acer Therapeutics Inc
ACER
$37K ﹤0.01%
16,200
– –
MRTN icon
3958
CALL
Marten Transport
MRTN
$1.18B
$36K ﹤0.01%
+26,000
New +$430K
NEM icon
3959
CALL
Newmont
NEM
$123B
$36K ﹤0.01%
+22,200
New +$1.26M
CME icon
3960
CALL
CME Group
CME
$93.9B
$35K ﹤0.01%
16,000
-2,500
-14% -$550K
LNC icon
3961
CALL
Lincoln National
LNC
$8.61B
$34K ﹤0.01%
+19,600
New +$1.38M
XERS icon
3962
Xeris Biopharma Holdings
XERS
$1.51B
$33K ﹤0.01%
+11,300
New +$24.4K
TMQ
3963
Trilogy Metals
TMQ
$677M
$31K ﹤0.01%
18,690
-200
-1% -$368
TXMD icon
3964
TherapeuticsMD
TXMD
$24.3M
$31K ﹤0.01%
1,747
-1,863
-52% -$55.8K
GYRE icon
3965
Gyre Therapeutics
GYRE
$705M
$30K ﹤0.01%
4,373
-12,901
-75% -$221K
UAVS icon
3966
AgEagle Aerial Systems
UAVS
$61.5M
$30K ﹤0.01%
+19
New +$46K
FNHC
3967
DELISTED
FedNat Holding Company Common Stock
FNHC
$30K ﹤0.01%
+21,017
New +$43K
NBEV
3968
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$30K ﹤0.01%
29,307
-36,290
-55% -$47.9K
HIVE
3969
HIVE Digital Technologies
HIVE
$731M
$29K ﹤0.01%
+2,240
New +$38.5K
CCEC
3970
CALL
Capital Clean Energy Carriers
CCEC
$1.35B
$29K ﹤0.01%
30,800
-27,000
-47% -$397K
TMDI
3971
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
$29K ﹤0.01%
46,254
-6,989
-13% -$7.88K
JPM icon
3972
CALL
JPMorgan Chase
JPM
$960B
$28K ﹤0.01%
70,500
-22,000
-24% -$3.61M
OGI
3973
Organigram Holdings
OGI
$165M
$28K ﹤0.01%
3,957
-8,093
-67% -$68.7K
SYBX
3974
DELISTED
Synlogic
SYBX
$27K ﹤0.01%
733
– –
TROX icon
3975
CALL
Tronox
TROX
$1.03B
$27K ﹤0.01%
15,300
+3,200
+26% +$76.6K
157 158
159
160 161

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, Raymond James & Associates held 4,396 positions worth $124B, up 11% from $111B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.01B of net new capital in Q4 2021, opening 293 new positions and adding to 2,114 existing holdings. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI All Country Asia ex Japan ETF, an estimated $80M trimmed.

  • Raymond James & Associates's largest Q4 2021 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 14,614 shares worth $21.8M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q4 2021, an estimated $212M increase.
  • Raymond James & Associates's biggest Q4 2021 reduction was iShares MSCI All Country Asia ex Japan ETF, cutting an estimated $80M.
  • Raymond James & Associates fully exited Kansas City Southern in Q4 2021, selling an estimated $80.8M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $124B portfolio in Q4 2021.
  • Raymond James & Associates opened 293 new positions and closed 268 in Q4 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $124B.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.